Status and phase
Conditions
Treatments
Study type
Funder types
Identifiers
About
This study will assess the immunogenicity of one dose of Gardasil and one dose of Gardasil-9
Full description
This is a one group exploratory study.
The main objective of this study is to assess the persistance of anti-HPV after a single dose Gardasil and the effect of one dose of Gardasil-9 when administered 3-8 years later.
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Inclusion Criteria: Have received a single dose of Gardasil 3-8 years before recruitement.
Exclusion Criteria: Immunossupressed or blood coagulation problems
Primary purpose
Allocation
Interventional model
Masking
32 participants in 1 patient group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal